The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation

In a recent article published by Pharmaceutical Commerce, EVERSANA’s Chris Cameron and Tim Reason explore how evolving health technology assessment (HTA) requirements, Joint Clinical Assessment (JCA) implementation and increasing pricing pressures are reshaping the commercialization landscape for biopharmaceutical companies. 

Read the full article in Pharmaceutical Commerce 

Navigating a New Era of Commercialization 

As healthcare stakeholders place greater emphasis on demonstrating value, the conversation highlights a significant industry shift: evidence generation can no longer be viewed as a one-time activity tied to launch. Instead, organizations must develop strategies that support continuous evidence generation throughout a product’s lifecycle. 

The article examines how manufacturers are adapting to changing market access expectations, strengthening their evidence strategies and leveraging technology to support more informed decision-making. 

A key theme throughout the discussion is the growing need to connect commercialization, value demonstration and evidence generation. As regulatory requirements evolve and payer scrutiny increases, successful organizations will be those that can continuously generate, evaluate and communicate evidence that supports both clinical and economic value. 

Expanding AI-Powered HEOR and Evidence Capabilities 

The feature also marks one of the first thought leadership articles involving Tim Reason, founder of Estima Scientific, since the company joined EVERSANA in October. The addition of Estima Scientific expanded EVERSANA’s AI-powered HEOR and evidence generation capabilities, further strengthening our ability to help biopharma organizations navigate increasingly complex market access and commercialization challenges. 

As the industry continues to evolve, continuous evidence generation is becoming a critical component of successful commercialization strategies.

Explore our HEOR, Value & Evidence capabilities

Author Team
no-image

EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…